AliveCor has announced that it has begun the rollout of its KardiaMobile technology to the NHS via the UK’s Academic Health Science Networks (AHSNs) as part of a project funded by NHS England to accelerate diagnosis of atrial fibrillation (AF), a potentially fatal heart rhythm condition.
Affecting 1.4 million people in the UK, and with an estimated 500,000 cases undiagnosed due to fleeting symptoms which may not be present under GP inspection, AF is the most common variety of heart arrhythmia and a contributing factor in up to 20% of strokes in the country.
Image caption:
Image Credit: AliveCor
